Actinium Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Actinium Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Actinium Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.84M, a 24.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.84M -$598K -24.5% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $1.99M -$591K -22.9% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $2.14M -$404K -15.9% Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $2.29M -$52K -2.22% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $2.44M -$18K -0.73% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $2.58M -$48K -1.83% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.54M +$2.39M +1574% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $2.34M +$2.1M +871% Dec 31, 2022 10-K 2024-03-29
Q3 2022 $2.45M +$2.13M +648% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.63M +$2.22M +537% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $152K -$344K -69.4% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $241K -$338K -58.4% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $328K -$331K -50.2% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $413K -$325K -44% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $496K -$319K -39.1% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $579K -$228K -28.3% Dec 31, 2020 10-K 2022-03-25
Q3 2020 $659K -$304K -31.6% Sep 30, 2020 10-Q 2020-10-23
Q2 2020 $738K -$298K -28.8% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $815K -$292K -26.4% Mar 31, 2020 10-Q 2020-06-30
Q4 2019 $807K Dec 31, 2019 10-K 2021-03-31
Q3 2019 $963K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.04M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $1.11M Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.